News

Novosanis receives Interreg CrossCare grant for its VAX-ID device

Posted on 7/03/2019

Novosanis receives grant from Interreg CrossCare to build a next-generation of its unique and patented intradermal drug delivery device, VAX-ID, in collaboration with living labs Happy...

Breakthrough results on VAX-ID for kids at 12th Vaccine Conference

Posted on 15/09/2018

Timothi Van Mulder will present Novosanis' breakthrough results on the development of a painless injection device for children at 12 th Vaccine Congress in Budapest, Hungary from September...

Novosanis attending Life Sciences week and BioJapan

Posted on 12/10/2016

Novosanis will present its VAX-ID™ device platform during BioJapan

Research on skin thickness published by Van Mulder and co-workers in prestigious journal 'Vaccine'

Posted on 25/08/2016

"High Frequency Ultrasound to Assess Skin Thickness in Healthy Adults” published in the prestigious peer-reviewed journal VACCINE.

You are here

Novosanis receives Interreg CrossCare grant for its VAX-ID device

Breakthrough results on VAX-ID for kids at 12th Vaccine Conference

Novosanis attending Life Sciences week and BioJapan

Research on skin thickness published by Van Mulder and co-workers in prestigious journal 'Vaccine'

Pages

novosanis